New findings about prednisone’s usage in DMD and MG featured at 2009 American Academy of Neurology meeting in Seattle
Some interesting findings about prednisone’s effect on behavior in DMD, and on drugs that may alter its usage in myasthenia gravis, were part of the 61st annual meeting of the American Academy of Neurology (AAN), held recently in Seattle.
Daily prednisone led to better behavior than weekly, high-dose prednisone
This story includes items about: Becker, Duchenne and limb-girdle muscular dystrophies; myasthenia gravis; carnitine palmityl transferase 2 deficiency; inclusion-body myopathy
Canadian team will pursue cell transplants in men with DMD, BMD
Closer look questions risks of medications for people with CMT
Worsening of Charcot-Marie-Tooth (CMT) disease as a result of medication use may not be as worrisome as popular belief has portrayed it, say investigators who recently culled data from medical literature and from 209 people in the CMT North American Database, an MDA-funded registry.
New treatments bring relief in inflammatory muscle disease, but patience is required
Giovanna Albers, 38, has recovered from her polymyositis and no longer takes medication for it. Her weight is back to normal, and she "lives and breathes" in the water. Photo by Tim Parker
In this issue: A protein called dysferlin may hold the answer to repairing muscle in MD ** Cardiac problems seen in Becker and Duchenne MD after childhood ** Fukuyama MD is found in a child not of Japanese descent ** and more...